Results 111 to 120 of about 1,148 (137)

Post-market surveillance of antiretroviral drug quality in Tanzania in the context of rising HIV drug resistance. [PDF]

Sci Rep
Mlugu EM, Mhagama JB, Sangeda RZ, Kunambi PP, Samwel T, Shiletiwa N, Gotora G, Chambiri SM, Matiko D, Hipolite D, Mwalwisi YH, Fimbo AM.   +11 more
europepmc   +1 more source

Quality of different brands of clarithromycin tablets marketed in Ethiopia; implications for the future. [PDF]

JAC Antimicrob Resist
Bayu WT, Ketema G, Kassahun H, Meyer JC, Godman B, Mekonnen BA.   +5 more
europepmc   +1 more source

Recent developments of Raman spectroscopy for the qualitative analysis of falsified and substandard medicines

, 2018
Coic, Laureen, Sacre, Pierre-Yves, Avohou, Tonakpon Hermane, Deidda, Riccardo, De Bleye, Charlotte, Dumont, Elodie, Marini Djang'Eing'A, Roland, Hubert, Philippe, Ziemons, Eric   +8 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Benchtop NMR spectroscopy in the analysis of substandard and falsified medicines as well as illegal drugs

Journal of Pharmaceutical and Biomedical Analysis, 2020
Substandard and falsified medical products may cause harm to patients and fail to treat the diseases or conditions for which they were intended. It is therefore required to have analytical methods available to assess medical product quality. Benchtop NMR spectroscopy provides a generic, inherently quantitative, analytical method capable of separating ...
Peter Keizers
exaly   +5 more sources

Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia

Social Science and Medicine
Substandard and falsified (SF) medicines are a global health problem. Their high prevalence is a threat to public health in low- and middle-income countries (LMICs). However, there are few street-level investigations of how this market works. This case study examines the supply and demand for SF medicines in Southern Ethiopia.A cross sectional ...
Linda Gibson, Robert Dingwall, Bastiaens H   +2 more
exaly   +4 more sources

Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains

2015
Lawrence Gostin, Sam Halabi
exaly   +2 more sources

Falsified and Substandard Medicines

2015
The circulation of poor-quality medicines, whether they are the result of drug falsification or substandard production, is a serious public health problem in low-income countries (LICs) and lower-middle-income countries (LMICs). The prevalence of poor-quality medicines varies considerably among countries and disproportionately affects countries with an
Tariq Almuzaini, Helen Sammons, Imti Choonara   +2 more
openaire   +1 more source

The hidden dangers of falsified and substandard medicines

2019
SWP Comment 25 ...
Vorrath, Judith, Voss, Maike, Stiftung Wissenschaft Und Politik   +2 more
openaire   +2 more sources

The Political Economy of Substandard and Falsified Medicines: An Evidence-Informed Risk-Assessment Framework Based on a Multi-Country Study

SSRN Electronic Journal, 2018
Background: Substandard and falsified medicines promote antimicrobial resistance and undermine progress towards universal health coverage. We investigated the political and economic factors that incentivise and facilitate the production, trade and consumption of these products.Methods: We conducted in-depth case studies in China, Indonesia, Turkey and ...
Pisani, Elizabeth, Nistor, Adina-Loredana, Hasnida, Amalia, Parmaksiz, Koray, Xu, Jingying, Kok, Maarten O   +5 more
openaire   +2 more sources